The vice president of the Drug Distribution Companies Association says drug fluctuations are just a number for officials.
Mahalati, vice president of the Drug Distribution Companies Association
Vahid Mahalati states that drug fluctuations might just be a few numbers, but from the patient’s perspective, it means numerous problems and significant discomfort.
It is the duty of all members of the drug supply chain to act in a way that does not create trouble and problems for patients.
Some drugs cannot be changed, and even the manufacturer of drugs like Warfarin cannot be changed because it can cause complications for the patient.
Therefore, talking about drug fluctuations is simple, but it creates serious problems for patients.
In the import sector, shortages or surpluses of drugs also create problems.
Sometimes there is a shortage of drugs, and with the sudden influx of liquidity, all factories rush to production, resulting in a surplus of drugs, which can cause more problems than a shortage.